Blog Archives

Deutschland: Drospirenon-haltige orale Kontrazeptiva (z.B. Yasmin®) – Aktualisierung der Produkt-Informationen zum Risiko venöser Thromboembolien

24. September 2011 – Ähnlich wie Swissmedic in der Schweiz (siehe untenstehende Blog-Post) hat kürzlich das BfArM in Deutschland zu den Risiken venöser thromboembolischer Ereignisse (VTE) bei der Anwendung drospirenonhaltiger kombinierter oraler Kontrazeptiva informiert. Frauen können nicht genügend auf dieses zwar seltene, jedoch real existierende Risiko (mit möglichem fatalen Ausgang) der medikamentösen Schwangerschaftsverhütung hingewiesen werden.

Read more ›

Tags: , , , , ,

Venöse Thromboembolien unter Antibabypillen : Swissmedic informiert über Abklärungen und erinnert an die Vorsichtsmassnahmen

28. Juli 2011 – Das Schweizerische Heilmittelinstitut (Swissmedic) hat heute folgendermassen informiert (Text im Wortlaut folgend):

_________________

Antibabypillen, die den Wirkstoff Drospirenon enthalten, sind im Risikobereich der anderen auf dem Markt erhältlichen Präparate. Das Risiko für Frauen, eine venöse Thromboembolie zu bekommen, ist wie bei allen Antibabypillen im ersten Jahr der Einnahme am stärksten erhöht.

Read more ›

Tags: , , , , , , ,

Drospirenon-haltige Kontrazeptiva: Risiko von Venenthrombosen und Lungenembolien mit den Produkten Yasmin, Yasminelle, und Yaz.

25. März 2010 – Einer heutigen Mitteilung können wir entnehmen, dass das Schweizerische Heilmittelinstitut (Swissmedic) das Überprüfungsverfahren der Drospirenon-haltigen Kontrazeptiva abgeschlossen hat.

Die Fach- und Patienteninformation der kombinierten oralen Kontrazeptiva (“Antibaby-Pillen”) Yasmin®, Yasminelle®, und Yaz®,

Read more ›

Tags: , , , , , , , , , ,

Swissmedic schliesst Überprüfung der Antibabypillen ab

22. Oktober 2009 –  Das Schweizerische Heilmittelinstitut (Swissmedic) hat heute die untenstehende  Mitteilung herausgegen. Sie betrifft Drospirenon-haltige Antibabypillen, welche in der Schweiz als Angeliq®, Yasmin®, Yasminelle®, und YAZ® auf dem Markt sind.

Antibabypillen,

Read more ›

Tags: , , , , , ,

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Distinct social profile and high ASD risk, 3q29 deletion survey finds July 19, 2019
    A survey of 93 people with 3q29 deletion syndrome reveals a distinct pattern of social disability and anxiety, even without a diagnosis of autism spectrum disorder. The results were published online in Molecular Autism on July 16.
  • Study sheds light on the darker parts of our genetic heritage July 19, 2019
    More than half of our genome consists of transposons,DNA sequences that are reminiscent of ancient, extinct viruses.Transposons are normally silenced by a process known as DNA methylation, but their activation can lead to serious diseases. Very little is known about transposons but researchers in an international collaboration project have now succeeded for the first time […]
  • Molecular cause for severe multi-organ syndrome July 19, 2019
    Three unrelated families on three continents (from continental Portugal, the United States and Brazil), all with healthy ancestors, had children with a very rare multi-organ condition that causes early-onset retinal degeneration, sensorineural hearing loss, microcephaly, intellectual disability, and skeletal dysplasia with scoliosis and short stature.
  • Researchers determine epigenetic origin of docetaxel-resistant breast cancer July 19, 2019
    Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have published a study in Molecular Cancer Research in which they identify methylation patterns associated with different subtypes of breast cancer, and a subclassification of the group of "triple negatives," a breast cancer type typically associated with poor prognosis. In addition, they identified changes in DNA methylation […]
  • Researchers report the function of reverse-twisting DNA July 19, 2019
    Normally, the two strands of the DNA double helix wind around each other in a right-handed spiral. However, there is another conformation called Z-DNA in which the strands twist to the left. The function of Z-DNA has remained a mystery since its discovery. A newly published paper unambiguously establishes that the Z-conformation is key to […]
  • Study sheds light on the darker parts of our genetic heritage July 19, 2019
    More than half of our genome consists of transposons, DNA sequences that are reminiscent of ancient, extinct viruses. Transposons are normally silenced by a process known as DNA methylation, but their activation can lead to serious diseases. Very little is known about transposons but researchers in an international collaboration project have now succeeded for the first time […]
  • Flexible user interface distribution for ubiquitous multi-device interaction July 19, 2019
    KAIST researchers have developed mobile software platform technology that allows a mobile application (app) to be executed simultaneously and more dynamically on multiple smart devices. Its high flexibility and broad applicability can help accelerate a shift from the current single-device paradigm to a multiple one, which enables users to utilize mobile apps in ways previously […]
  • Atomically precise models improve understanding of fuel cells July 19, 2019
    Simulations from researchers in Japan provide new insights into the reactions occurring in solid-oxide fuel cells by using realistic atomic-scale models of the electrode active site based on microscope observations instead of the simplified and idealized atomic structures employed in previous studies. This better understanding of how the structures in the cells affect the reactions […]
  • Predicting long-term risk of death from chest X-rays July 19, 2019
    Researchers in this study looked at whether a computing system that analyzed data from thousands of chest X-rays of smokers and nonsmokers and developed a risk score could predict long-term risk of death.
  • Ivacaftor may reduce common infections in patients with CF July 19, 2019
    Patients with cystic fibrosis who take ivacaftor appear to have fewer respiratory infections over time than those not taking the drug, according to new research published online in the Annals of the American Thoracic Society.
Top